Zimmer Biomet Holdings Inc (ZBH)
Net profit margin
Dec 31, 2024 | Sep 30, 2024 | Jun 30, 2024 | Mar 31, 2024 | Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 | Dec 31, 2020 | Sep 30, 2020 | Jun 30, 2020 | Mar 31, 2020 | ||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Net income (ttm) | US$ in thousands | 903,800 | 1,083,500 | 997,100 | 963,900 | 1,024,000 | 474,300 | 505,600 | 449,700 | 231,400 | 277,900 | 229,500 | 217,700 | 401,600 | 819,300 | 916,200 | 567,700 | -138,900 | -151,900 | 36,700 | 377,000 |
Revenue (ttm) | US$ in thousands | 7,434,500 | 7,373,400 | 7,289,700 | 7,214,600 | 7,171,500 | 7,054,100 | 6,993,800 | 6,933,800 | 6,780,400 | 6,827,800 | 7,061,000 | 7,290,300 | 7,452,200 | 7,716,200 | 7,722,600 | 6,923,200 | 6,840,900 | 6,881,300 | 6,840,200 | 7,596,700 |
Net profit margin | 12.16% | 14.69% | 13.68% | 13.36% | 14.28% | 6.72% | 7.23% | 6.49% | 3.41% | 4.07% | 3.25% | 2.99% | 5.39% | 10.62% | 11.86% | 8.20% | -2.03% | -2.21% | 0.54% | 4.96% |
December 31, 2024 calculation
Net profit margin = Net income (ttm) ÷ Revenue (ttm)
= $903,800K ÷ $7,434,500K
= 12.16%
Zimmer Biomet Holdings Inc's net profit margin has shown fluctuations over the periods provided. The net profit margin is a key profitability ratio that indicates the company's effectiveness in generating profits from its revenue after accounting for all expenses.
The trend in Zimmer Biomet's net profit margin indicates some volatility, with positive margins in some quarters and negative margins in others. For example, the net profit margin was negative in the third and fourth quarters of 2020, indicating that the company incurred losses during those periods.
However, the company's performance improved in subsequent quarters, with the net profit margin showing an upward trajectory through 2021 and into 2024. The highest net profit margin was recorded in the fourth quarter of 2024 at 14.69%, indicating that Zimmer Biomet was able to significantly increase its profitability during that period.
Overall, it is essential to monitor Zimmer Biomet's net profit margin closely to assess its profitability and financial health consistently. While improvements have been observed in recent quarters, the company should continue to focus on cost management and revenue generation strategies to sustain and enhance its profitability in the long run.
Peer comparison
Dec 31, 2024